TargetRx to Deliver Plenary Address at Pharmaceutical Summit
Pharmaceutical Sales & Marketing Expert to Present Company's Latest Insights
Horsham, PA - November 2, 2007 - TargetRx today announced that the company's President and CEO Mike Luby will deliver a plenary address at the upcoming Pharmaceutical Executive Marketing & Sales Summit to be held November 4-6, 2007 in Philadelphia.
This second annual conference from Pharmaceutical Executive will address the most critical issues and changes impacting pharmaceutical and biopharmaceutical marketing and sales executives. This year's program features presentations from top executives at Lilly USA, GlaxoSmithKline and Abbott, among others.
Pharmaceutical Executive's Marketing & Sales
Summit
November 4-6, 2007, Pennsylvania Convention Center, Philadelphia,
PA
Opening Address: "How Pharmaceutical Companies Can Measure, Manage and
Improve Sales and Marketing Effectiveness"
Tuesday, November 6, 2007, 8:05-8:45 a.m.
Following the opening remarks from Patrick Clinton, Editor-in-Chief of Pharmaceutical Executive, Luby will present TargetRx's latest insights into sales and marketing quality and recent acknowledgements by pharmaceutical companies of the importance of improving the effectiveness and efficiency of sales and marketing in the current environment. TargetRx has ground-breaking insights based on more than six years of research into the methods by which pharmaceutical companies can measure, manage, and improve the performance of sales and marketing.
In his presentation, Luby will review the factors that are critical to successful execution, highlight sales and marketing industry trends and forecast opportunities that will play out in the near future. While the industry knows it needs to improve the efficiency of its sales and marketing efforts - with many pharmaceutical companies downsizing field forces, reorganizing existing ones and piloting new approaches - no one seems to have cracked the code on sales and marketing effectiveness. This opening address will provide insight into several sales and marketing strategies and how pharmaceutical companies are executing to make sales and marketing more effective. Luby's presentation will be followed by the keynote address from Martin Soeters, President of Novo Nordisk.
For more information or to register for this event, visit:
http://www.pharmexecsummit.com/pharmexecsummit/v42/index.cvn?id=10000
About TargetRx
TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their brands, helping clients to confidently take the actions that will grow their businesses and help patients. Serving the majority of the top 30 pharmaceutical and biotech companies, TargetRx enables clients to significantly improve the launch of new products and indications, physician segmentation and targeting, creation of professional messaging and materials, and sales and marketing execution and effectiveness. All TargetRx solutions are powered by our AdvantageBuilderSM normative database and validated predictive models, created from capturing in-depth physician attitudes on the "four forces" of prescribing - product, payor, promotion and patient - on new launches, marketing campaigns and physician-rep interactions on over 500 pipeline and inline brands and modeling these attitudes against actual prescribing behavior. For more information, visit www.targetrx.com.
Media Contact:
Joe FordPhone: 215-444-8722
jford@targetrx.com